About Akdeniz Universitesi Tip Fakultesi
Clinical Trials at Akdeniz Universitesi Tip Fakultesi
During the past decade, Akdeniz Universitesi Tip Fakultesi conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on
average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Akdeniz Universitesi Tip Fakultesi" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Pfizer" with 3 trials
sponsored, "Amgen" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Incyte Corporation"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Akdeniz Universitesi Tip Fakultesi"
#1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Akdeniz Universitesi Tip Fakultesi
According to Clinical.Site data, the most researched conditions in "Akdeniz Universitesi Tip Fakultesi" are
"Cardiovascular Disease" (2 trials), "Venous Thromboembolism" (2 trials), "Active Systemic Lupus Erythematosus" (1 trials), "Anemia" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Akdeniz Universitesi Tip Fakultesi" in a lesser frequency.
Clinical Trials Intervention Types at Akdeniz Universitesi Tip Fakultesi
Most popular intervention types in "Akdeniz Universitesi Tip Fakultesi" are "Drug" (12 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Epacadostat" (2 trials), "Pembrolizumab" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "dabigatran etexilate" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Akdeniz Universitesi Tip Fakultesi
The vast majority of trials in "Akdeniz Universitesi Tip Fakultesi" are
12 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Akdeniz Universitesi Tip Fakultesi
Currently, there are NaN active trials in "Akdeniz Universitesi Tip Fakultesi".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Akdeniz Universitesi Tip Fakultesi,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Akdeniz Universitesi Tip Fakultesi, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".